Adjuvant chemotherapy is ineffective in patients with bladder cancer and variant histology treated with radical cystectomy
Main Authors: | S. Zamboni, P. Baumeister, A. Aziz, C. Poyet, C. Simeone, A. Antonelli, F. Roghmann, A. Meraney, B.R. Konety, F. Montorsi, A. Gallina, A. Briganti, G. Gandaglia, E. Zaffuto, G. Simone, R.J. Karnes, K. Hendricksen, C.S. Voskuilen, A. Mattei, L. Afferi, M. Rink, A. Necchi, S.F. Shariat, E. Xylinas, M. Moschini |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-07-01
|
Series: | European Urology Open Science |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2666168320336570 |
Similar Items
-
No-response at mpMRI after neoadjuvant pembrolizumab is a proxy of adverse pathological and oncological outcomes in patients treated with radical cystectomy: Interim results from the PURE01 study
by: M. Bandini, et al.
Published: (2020-07-01) -
Impact of histological variants in node positive patients treated with radical cystectomy for bladder cancer
by: M. Bandini, et al.
Published: (2020-07-01) -
No-response at mpMRI after neoadjuvant pembrolizumab is a proxy of adverse pathological and oncological outcomes in patients treated with radical cystectomy: interim results from the PURE01 study
by: G. Basile, et al.
Published: (2020-10-01) -
Impact of histological variants in node positive patients treated with radical cystectomy for bladder cancer
by: M. Bandini, et al.
Published: (2020-10-01) -
No impact on disease recurrence or progression of the stage at re-TUR in Ta high-grade bladder cancer patients treated with BCG: A multi-center collaboration of EAU Young Academic Urologists Urothelial Carcinoma Group
by: S. Régnier, et al.
Published: (2020-07-01)